Lifecore Biomedical, Inc. (LFCR) News
Follow Lifecore Biomedical, Inc. (LFCR) news in one place: company catalysts, earnings, analyst actions and wider market developments. Review 22 public stories across 9 publication days to understand how the story developed. Public news appears after a 15-minute delay; LiveCast subscribers can follow new headlines and hear important updates without this additional delay.
M
Lifecore Biomedical Q3 earnings snapshot
Lifecore Biomedical reported a third-quarter result, but the supplied body is truncated before details are available.
EQUITY | Nov 04, 2026, 12:28 PM UTC
M
Lifecore Biomedical Reports Higher Q3 Net Loss and Lower Revenue
Lifecore Biomedical reported a higher third-quarter net loss and lower third-quarter revenue.
EQUITY | Nov 04, 2026, 12:23 PM UTC
M
Lifecore Biomedical Reports Q3 Revenue of $25.3 Million
Q3 revenue was $25.3 million, versus the IBES estimate of $26.7 million.
EQUITY | Nov 04, 2026, 12:22 PM UTC
M
Lifecore Biomedical Reports Third-Quarter Loss of $1.08 per Share
EQUITY | Nov 04, 2026, 12:22 PM UTC
H
Lifecore Biomedical Q2 2026 Earnings Call Transcript
Lifecore Biomedical (NASDAQ: LFCR ) held its second-quarter earnings conference call on Wednesday. Below is the complete transcript from the call. This content is powered APIs. For comprehensive financial data and transc
LIVE | Oct 08, 2026, 08:17 AM UTC
H
Deal Dispatch: Hormel Acquires Brakebush, Onsemi buys Synaptics for $5.7 Billion, Leslie’s Pools Bankruptcy
New On The Block Hyperscale Data, Inc. (NYSE: GPUS ), an artificial intelligence data center company, is holding discussions regarding a sale of its askROI, Inc. subsidiary and its AI business. Updates From The Block Val
LIVE | Oct 02, 2026, 05:35 PM UTC
L
Lifecore Biomedical Extends Alcon Manufacturing Pact to 2034 With Minimum Purchase Commitments
Lifecore Biomedical entered into Amendment No. 3 to its Amended and Restated Contract Manufacturing Agreement with Alcon, effective November 1, 2026. The amendment extends the agreement through December 31, 2034, adds Al
NEWS | Sep 29, 2026, 08:13 PM UTC
L
Lifecore Biomedical Cut to Market Perform From Outperform by Barrington Research
Ratings actions from Benzinga
NEWS | Sep 29, 2026, 04:14 PM UTC
L
Lifecore Biomedical Cut to Market Perform From Outperform by William Blair
Ratings actions from Benzinga
NEWS | Sep 28, 2026, 06:33 PM UTC
L
Lifecore Biomedical Shares Rally With Deal to Be Acquired by Webster Equity Partners
By Robb M. StewartLifecore Biomedical's shares jumped Monday after the company agreed to be bought by Webster Equity Partners in a transaction valued at up to $663.7 million.The contract manufacturer of syringes and othe
EQUITY | Sep 28, 2026, 02:58 PM UTC
L
Lifecore Biomedical to Be Acquired by Webster Equity Partners for Up to $663.7 Million
By Robb M. StewartLifecore Biomedical has agreed to be bought by Webster Equity Partners in a transaction valued at up to $663.7 million.The contract manufacturer of syringes and other injectable pharmaceutical products
NEWS | Sep 28, 2026, 01:34 PM UTC
L
Lifecore Biomedical to Be Taken Private by Webster Affiliates in $6.28-Per-Share Cash Deal Plus CVR
Lifecore Biomedical agreed to be acquired by affiliates of Webster Equity Partners in a take-private transaction that pays shareholders $6.28 in cash per share plus one contingent value right (CVR). The CVR framework inc
NEWS | Sep 28, 2026, 01:07 PM UTC
L
Lifecore Biomedical, Inc. (LFCR) To Be Acquired for $6.28/Share Cash Plus CVR
Lifecore agreed to be acquired by Webster Equity Partners for $6.28 per share in cash plus a non-tradable CVR worth up to $160M, subject to milestones. Closing is expected by end of Q4 2026, pending approvals.Material De
NEWS | Sep 28, 2026, 12:49 PM UTC
L
Lifecore Biomedical to be Acquired by Webster Equity Partners
CHASKA, Minn. and WALTHAM, Mass., Sept. 28, 2026 (GLOBE NEWSWIRE) -- Lifecore Biomedical, Inc. NASDAQ:LFCR today announced that it has entered into a definitive agreement to be acquired by Webster Equity Partners in a tr
NEWS | Sep 28, 2026, 12:49 PM UTC
M
Lifecore Biomedical to be acquired by Webster Equity Partners
Lifecore Biomedical said it will be acquired by Webster Equity Partners.
MNA | Sep 28, 2026, 12:45 PM UTC
L
Lifecore Biomedical to participate at CPHI Global Conference
Lifecore Biomedical, Inc. (NASDAQ: LFCR) said it will participate at the CPHI Global Conference in 2026.
EQUITY | Sep 03, 2026, 08:07 PM UTC
L
LFCR - Lifecore Biomedical to Participate at CPHI Global Conference
LFCR - Lifecore Biomedical to Participate at CPHI Global Conference
EQUITY | Sep 03, 2026, 08:06 PM UTC
M
Lifecore Biomedical signs site-transfer agreement supporting pharma commercialization
Lifecore Biomedical (LFCR) signed an agreement for a commercial site transfer supporting a global pharmaceutical company’s tech transfer and commercial manufacturing of a currently marketed drug product.
EQUITY | Sep 02, 2026, 11:07 AM UTC
L
Lifecore Biomedical signs commercial site transfer agreement
Lifecore Biomedical (LFCR) signed an agreement for commercial site transfer supporting a global pharmaceutical company.
EQUITY | Sep 02, 2026, 11:05 AM UTC
L
Lifecore Biomedical Affirms FY2026 Sales Guidance of $120.000M-$125.000M vs $122.176M Est
Lifecore Biomedical (NASDAQ: LFCR ) affirms FY2026 sales outlook from $120.000 million-$125.000 million to $120.000 million-$125.000 million vs $122.176 million estimate.
EARNINGS | Aug 05, 2026, 11:06 AM UTC
L
LFCR - Lifecore Biomedical Reports Financial Results for the Second Quarter Ended June 30, 2026, and Provides Corporate Update - Click For R
LFCR - Lifecore Biomedical Reports Financial Results for the Second Quarter Ended June 30, 2026, and Provides Corporate Update
EARNINGS | Aug 05, 2026, 11:05 AM UTC
L
LFCR - Lifecore Biomedical to Report Financial Results for the Second Quarter Ended June 30, 2026, on August 5, 2026
LFCR - Lifecore Biomedical to Report Financial Results for the Second Quarter Ended June 30, 2026, on August 5, 2026
EARNINGS | Jul 29, 2026, 08:05 PM UTC